Clover Health Investments (CLOV) Stock: Buy, Sell, or Hold?
CLOV - Clover Health Investments, Corp
$4.82
0.11 (2.34%)
▲
5d:
+13.28%
30d:
+6.17%
90d:
-1.63%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 03, 2026
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Sep 9, 2026 at $4.28 · last confirmed Sep 9, 2026
Strength: 5.7/10
Get Alerted When CLOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CLOV shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CLOV shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CLOV is currently trading at $4.82, which is considered extended relative to its 30-day fair value range of $4.15 to $4.55. From a valuation perspective, the stock is trading at a discount (Forward PE: 32.1) compared to its historical average (35.8). Remarkably, the market is currently pricing in an annual earnings decline of 3.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CLOV is in a uptrend. The price is approaching resistance at $4.84. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CLOV scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CLOV is in a uptrend. The price is approaching resistance at $4.84. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CLOV scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.15 -
$4.55
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
19.0%
Protect Your Profits
Holding CLOV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.9% above its trading range)
- BEARISH: Weak technical setup (20/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($5.17)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.15 -
$4.55
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.12
Resistance Level
$4.84
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
32.13
Wall Street Target
$5.17
(+7.2%)
Revenue Growth (YoY)
55.6%
Profit Margin
-0.7%
Valuation Discount vs History
-3.5% cheaper
PE vs Historical
32.1 vs 35.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.5%
(market-implied from PE analysis)
1-Year Target
$4.65
(-4%)
2-Year Target
$4.49
(-7%)
3-Year Target
$4.33
(-10%)
3-Yr Target (if PE normalizes)
(PE: 32→36)
$4.83
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 32.1, Growth: 7.1%)
$5.93
(+23%)
Base:
(SPY PE: 20.2, Growth: 7.1%)
$3.72
(-23%)
Bear:
(PE: 17.1, Growth: 7.1%)
$3.16
(-34%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 32.1 to 35.8
Stabilization Target:
$5.37
(+11.4%)
PE Expansion Potential:
+11.4%
Share & Embed Analysis
Last updated: September 12, 2026 10:53 AM ET
Data refreshes hourly during market hours. Next update: 11:53 AM
Data refreshes hourly during market hours. Next update: 11:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLOV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$116 | 50 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$475 | 49 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 51 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$449 | 45 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$419 | 49 HOLD |
Advanced CLOV Option Strategies
Professional options setups generated by AI based on today's CLOV price and gamma walls.
